Gitler; Aaron D.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Gitler; Aaron D..The latest application filed is for "yeast cells expressing tar dna-binding protein 43 and uses therefor".

Company Profile

1.18.15

Gitler; Aaron D. - Philadelphia PA
Gitler; Aaron D. - Foster City CA
Gitler; Aaron D. - Quincy MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Modulators of alpha-synuclein toxicity Grant 10,526,651 - Lindquist , et al. J	2020-01-07
Yeast cells expressing TAR DNA-binding protein 43 and uses therefor Grant 10,428,335 - Lindquist , et al. October 1, 2	2019-10-01
Yeast Cells Expressing Tar Dna-binding Protein 43 And Uses Therefor App 20190010507 - Lindquist; Susan L. ; et al.	2019-01-10
Yeast cells expressing TAR DNA-binding protein 43 and uses therefor Grant 10,106,803 - Lindquist , et al. October 23, 2	2018-10-23
Modulators of alpha-synuclein toxicity Grant 9,909,160 - Lindquist , et al. March 6, 2	2018-03-06
Modulators of alpha-synuclein toxicity Grant 9,879,257 - Lindquist , et al. January 30, 2	2018-01-30
Yeast Cells Expressing Tar Dna-binding Protein 43 And Uses Therefor App 20170321222 - Lindquist; Susan L. ; et al.	2017-11-09
Yeast cells expressing TAR DNA-binding protein 43 and uses therefor Grant 9,738,898 - Lindquist , et al. August 22, 2	2017-08-22
Modulators Of Alpha-synuclein Toxicity App 20160215321 - Lindquist; Susan L. ; et al.	2016-07-28
Modulators Of Alpha-synuclein Toxicity App 20160046933 - Lindquist; Susan L. ; et al.	2016-02-18
Modulators of alpha-synuclein toxicity Grant 9,249,444 - Lindquist , et al. February 2, 2	2016-02-02
Novel Gene Targets Associated with Amyotrophic Lateral Sclerosis and Methods of Use Thereof App 20150252424 - Gitler; Aaron D.	2015-09-10
Modulators of alpha-synuclein toxicity Grant 9,018,003 - Lindquist , et al. April 28, 2	2015-04-28
Gene targets associated with amyotrophic lateral sclerosis and methods of use thereof Grant 8,969,005 - Gitler March 3, 2	2015-03-03
Methods of identifying modulators of TDP-43 mediated cellular toxicity Grant 8,865,411 - Gitler , et al. October 21, 2	2014-10-21
Modulators Of Alpha-synuclein Toxicity App 20140051091 - Lindquist; Susan L. ; et al.	2014-02-20
Modulators Of Alpha-synuclein Toxicity App 20130244903 - Lindquist; Susan L. ; et al.	2013-09-19
Modulators of alpha-synuclein toxicity Grant 8,501,465 - Lindquist , et al. August 6, 2	2013-08-06
Modulators of alpha-synuclein toxicity Grant 8,399,241 - Lindquist , et al. March 19, 2	2013-03-19
Novel Gene Targets Associated with Amyotrophic Lateral Sclerosis and Methods of Use Thereof App 20130059757 - Gitler; Aaron D.	2013-03-07
Modulators of TDP-43 Mediated Toxicity and Methods of Use Thereof for Identifying Agents Having Efficacy for the Treatment and Prevention of Proteinopathies App 20120237499 - Gitler; Aaron D. ; et al.	2012-09-20
Compositions and Methods for the Diagnosis and Treatment of Amyotrophic Lateral Sclerosis App 20110142789 - Gitler; Aaron D. ; et al.	2011-06-16
Modulators Of Alpha-synuclein Toxicity App 20110064722 - Lindquist; Susan L. ; et al.	2011-03-17
Yeast Cells Expressing Tar Dna-binding Protein 43 And Uses Therefor App 20110053857 - Lindquist; Susan L. ; et al.	2011-03-03
Modulators Of Alpha-synuclein Toxicity App 20090304664 - Lindquist; Susan L. ; et al.	2009-12-10
Modulators Of Alpha-synuclein Toxicity App 20090099069 - Lindquist; Susan L. ; et al.	2009-04-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.